Exact Mass: 321.3031

Exact Mass Matches: 321.3031

Found 31 metabolites which its exact mass value is equals to given mass value 321.3031, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Alpha-Linolenoyl ethanolamide

(9Z,12Z,15Z)-N-(2-hydroxyethyl)octadeca-9,12,15-trienamide

C20H35NO2 (321.2668)


alpha-Linolenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249) [HMDB] alpha-Linolenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249).

   

motuporamine E

motuporamine E

C20H39N3 (321.3144)


   

2E-N-hexadecenoylpiperidine|piperlongimin B

2E-N-hexadecenoylpiperidine|piperlongimin B

C21H39NO (321.3031)


   

cylindricine D

cylindricine D

C20H35NO2 (321.2668)


   

2,16-Kauranediol

2,16-Kauranediol

C21H37O2 (321.2793)


   

Alpha-Linolenoyl ethanolamide

Alpha-Linolenoyl ethanolamide

C20H35NO2 (321.2668)


CONFIDENCE standard compound; INTERNAL_ID 34

   

(1S,Z)-3-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-1-methyloctahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R,E)-7-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-1-methyloctahydro-2H-quinolizin-1-ol

C20H35NO2 (321.2668)


   

(1S,Z)-3-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-1-methyloctahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R,E)-6-hydroxy-2,5-dimethyloct-4-en-1-ylidene)-1-methyloctahydro-2H-quinolizin-1-ol

C20H35NO2 (321.2668)


   

(2R)-1-((1S,Z)-1-hydroxy-1-methylhexahydro-2H-quinolizin-3(4H)-ylidene)-2,5-dimethyloctan-4-one

(2R)-1-((1S,Z)-1-hydroxy-1-methylhexahydro-2H-quinolizin-3(4H)-ylidene)-2,5-dimethyloctan-4-one

C20H35NO2 (321.2668)


   

Anandamide (18:3, n-6)

N-(6Z,9Z,12Z-octadecatrienoyl)-ethanolamine

C20H35NO2 (321.2668)


   

α-Linolenoyl Ethanolamide

N-(2-hydroxyethyl)-9Z,12Z,15Z-octadecatrienamide

C20H35NO2 (321.2668)


   

NAE 18:3

N-(9Z,12Z,15Z-octadecatrienoyl)-ethanolamine

C20H35NO2 (321.2668)


   
   

N,N-DIMETHYL-2,(2-(4-(2,4,4-TRIMETHYL PENTAN-2-YL)PHENOXY) ETHOXY)ETHANAMINE

N,N-DIMETHYL-2,(2-(4-(2,4,4-TRIMETHYL PENTAN-2-YL)PHENOXY) ETHOXY)ETHANAMINE

C20H35NO2 (321.2668)


   

Rosiptor

Rosiptor

C20H35NO2 (321.2668)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Dihexyverine

Dihexyverine

C20H35NO2 (321.2668)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

(2R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol

(2R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol

C20H35NO2 (321.2668)


   

FTY720 methyl ether

FTY720 methyl ether

C20H35NO2 (321.2668)


   

N-(6Z,9Z,12Z-octadecatrienoyl)-ethanolamine

N-(6Z,9Z,12Z-octadecatrienoyl)-ethanolamine

C20H35NO2 (321.2668)


   

NA-Histamine 14:0

NA-Histamine 14:0

C19H35N3O (321.278)


   

alpha-Linolenoyl-EA

alpha-Linolenoyl-EA

C20H35NO2 (321.2668)


   

gamma-Linolenoyl-EA

gamma-Linolenoyl-EA

C20H35NO2 (321.2668)


   

Linolenoyl-EA

Linolenoyl-EA

C20H35NO2 (321.2668)


   

(3-aminopropyl)[3-(1-azacyclopentadeca-6,9-dien-1-yl)propyl]amine

(3-aminopropyl)[3-(1-azacyclopentadeca-6,9-dien-1-yl)propyl]amine

C20H39N3 (321.3144)


   

(3r,5s,7ar,11ar)-5-hexyl-3-(methoxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

(3r,5s,7ar,11ar)-5-hexyl-3-(methoxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

C20H35NO2 (321.2668)


   

5-hexyl-3-(methoxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

5-hexyl-3-(methoxymethyl)-decahydropyrrolo[2,1-j]quinolin-7-one

C20H35NO2 (321.2668)


   

(2e)-1-(piperidin-1-yl)hexadec-2-en-1-one

(2e)-1-(piperidin-1-yl)hexadec-2-en-1-one

C21H39NO (321.3031)


   

(3-aminopropyl)({3-[(6z,10e)-1-azacyclopentadeca-6,10-dien-1-yl]propyl})amine

(3-aminopropyl)({3-[(6z,10e)-1-azacyclopentadeca-6,10-dien-1-yl]propyl})amine

C20H39N3 (321.3144)


   

(3-aminopropyl)({3-[(6z,9z)-1-azacyclopentadeca-6,9-dien-1-yl]propyl})amine

(3-aminopropyl)({3-[(6z,9z)-1-azacyclopentadeca-6,9-dien-1-yl]propyl})amine

C20H39N3 (321.3144)


   

1-(piperidin-1-yl)hexadec-2-en-1-one

1-(piperidin-1-yl)hexadec-2-en-1-one

C21H39NO (321.3031)